annual D&A:
$236.19M+$6.79M(+2.96%)Summary
- As of today (September 18, 2025), AMRX annual depreciation & amortization is $236.19 million, with the most recent change of +$6.79 million (+2.96%) on December 31, 2024.
- During the last 3 years, AMRX annual D&A has risen by +$2.79 million (+1.19%).
- AMRX annual D&A is now -1.66% below its all-time high of $240.18 million, reached on December 31, 2022.
Performance
AMRX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$60.11M-$46.00K(-0.08%)Summary
- As of today (September 18, 2025), AMRX quarterly depreciation & amortization is $60.11 million, with the most recent change of -$46.00 thousand (-0.08%) on June 30, 2025.
- Over the past year, AMRX quarterly D&A has increased by +$4.54 million (+8.17%).
- AMRX quarterly D&A is now -9.10% below its all-time high of $66.13 million, reached on December 31, 2024.
Performance
AMRX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$245.36M+$4.54M(+1.89%)Summary
- As of today (September 18, 2025), AMRX TTM depreciation & amortization is $245.36 million, with the most recent change of +$4.54 million (+1.89%) on June 30, 2025.
- Over the past year, AMRX TTM D&A has increased by +$20.12 million (+8.93%).
- AMRX TTM D&A is now at all-time high.
Performance
AMRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AMRX Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.0% | +8.2% | +8.9% |
| 3 y3 years | +1.2% | +0.7% | +2.7% |
| 5 y5 years | +14.0% | +3.5% | +9.6% |
AMRX Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1.7% | +3.0% | -9.1% | +8.3% | at high | +8.9% |
| 5 y | 5-year | -1.7% | +14.0% | -9.1% | +8.3% | at high | +9.6% |
| alltime | all time | -1.7% | >+9999.0% | -9.1% | +9018.8% | at high | >+9999.0% |
AMRX Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $60.11M(-0.1%) | $245.36M(+1.9%) |
| Mar 2025 | - | $60.16M(-9.0%) | $240.82M(+2.0%) |
| Dec 2024 | $236.19M(+3.0%) | $66.13M(+12.2%) | $236.19M(+4.1%) |
| Sep 2024 | - | $58.96M(+6.1%) | $226.99M(+0.8%) |
| Jun 2024 | - | $55.57M(+0.1%) | $225.24M(-0.7%) |
| Mar 2024 | - | $55.53M(-2.5%) | $226.78M(-1.1%) |
| Dec 2023 | $229.40M(-4.5%) | $56.93M(-0.5%) | $229.40M(-1.8%) |
| Sep 2023 | - | $57.21M(+0.2%) | $233.52M(-1.9%) |
| Jun 2023 | - | $57.11M(-1.8%) | $237.93M(-1.1%) |
| Mar 2023 | - | $58.15M(-4.8%) | $240.51M(+0.1%) |
| Dec 2022 | $240.18M(+2.9%) | $61.06M(-0.9%) | $240.18M(-0.1%) |
| Sep 2022 | - | $61.61M(+3.2%) | $240.30M(+0.6%) |
| Jun 2022 | - | $59.70M(+3.3%) | $238.88M(+1.4%) |
| Mar 2022 | - | $57.81M(-5.5%) | $235.67M(+1.0%) |
| Dec 2021 | $233.41M(-0.8%) | $61.18M(+1.7%) | $233.41M(+0.6%) |
| Sep 2021 | - | $60.19M(+6.5%) | $232.10M(+0.4%) |
| Jun 2021 | - | $56.49M(+1.7%) | $231.27M(-0.7%) |
| Mar 2021 | - | $55.55M(-7.2%) | $232.85M(-1.1%) |
| Dec 2020 | $235.39M(+13.6%) | $59.87M(+0.9%) | $235.39M(+2.4%) |
| Sep 2020 | - | $59.36M(+2.2%) | $229.82M(+2.7%) |
| Jun 2020 | - | $58.07M(-0.0%) | $223.82M(+3.4%) |
| Mar 2020 | - | $58.08M(+7.0%) | $216.45M(+4.4%) |
| Dec 2019 | $207.24M(+50.8%) | $54.30M(+1.8%) | $207.24M(+3.4%) |
| Sep 2019 | - | $53.36M(+5.2%) | $200.43M(+5.4%) |
| Jun 2019 | - | $50.71M(+3.8%) | $190.08M(+10.8%) |
| Mar 2019 | - | $48.87M(+2.9%) | $171.52M(+24.8%) |
| Dec 2018 | $137.40M(+199.1%) | $47.49M(+10.4%) | $137.40M(+33.7%) |
| Sep 2018 | - | $43.01M(+33.8%) | $102.75M(+43.3%) |
| Jun 2018 | - | $32.15M(+117.9%) | $71.70M(+81.3%) |
| Mar 2018 | - | $14.75M(+14.9%) | $39.55M(+59.5%) |
| Dec 2017 | $45.94M(-48.0%) | $12.84M(+7.4%) | $24.80M(-33.3%) |
| Sep 2017 | - | $11.96M(-52.6%) | $37.20M(-57.9%) |
| Dec 2016 | $88.35M(+28.7%) | - | - |
| Dec 2016 | - | $25.25M(-5.4%) | $88.35M(+6.3%) |
| Sep 2016 | - | $26.68M(+28.9%) | $83.07M(+11.7%) |
| Jun 2016 | - | $20.70M(+31.7%) | $74.34M(+0.6%) |
| Mar 2016 | - | $15.72M(-21.3%) | $73.92M(+7.7%) |
| Dec 2015 | $68.64M(+101.7%) | $19.97M(+11.3%) | $68.64M(+18.1%) |
| Sep 2015 | - | $17.95M(-11.5%) | $58.14M(+20.0%) |
| Jun 2015 | - | $20.27M(+94.1%) | $48.44M(+32.9%) |
| Mar 2015 | - | $10.44M(+10.2%) | $36.45M(+7.1%) |
| Dec 2014 | $34.03M(-5.5%) | $9.47M(+14.9%) | $34.03M(+13.1%) |
| Sep 2014 | - | $8.25M(-0.5%) | $30.07M(+6.9%) |
| Jun 2014 | - | $8.29M(+3.4%) | $28.13M(-11.0%) |
| Mar 2014 | - | $8.02M(+45.1%) | $31.62M(-12.2%) |
| Dec 2013 | $36.01M | $5.52M(-12.4%) | $36.01M(-57.7%) |
| Sep 2013 | - | $6.30M(-46.5%) | $85.14M(-5.4%) |
| Jun 2013 | - | $11.78M(-5.0%) | $89.97M(+3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | $12.40M(-77.3%) | $86.61M(+11.1%) |
| Dec 2012 | $77.93M(+397.0%) | $54.66M(+391.2%) | $77.93M(+187.9%) |
| Sep 2012 | - | $11.13M(+32.1%) | $27.07M(+38.9%) |
| Jun 2012 | - | $8.42M(+126.3%) | $19.49M(+22.2%) |
| Mar 2012 | - | $3.72M(-2.0%) | $15.95M(+1.7%) |
| Dec 2011 | $15.68M(+24.0%) | $3.80M(+7.2%) | $15.68M(+1.4%) |
| Sep 2011 | - | $3.54M(-27.4%) | $15.47M(+3.7%) |
| Jun 2011 | - | $4.88M(+41.2%) | $14.92M(+13.4%) |
| Mar 2011 | - | $3.46M(-3.5%) | $13.16M(+4.0%) |
| Dec 2010 | $12.65M(+12.3%) | $3.58M(+19.5%) | $12.65M(+1.0%) |
| Sep 2010 | - | $3.00M(-4.0%) | $12.53M(+3.2%) |
| Jun 2010 | - | $3.12M(+6.0%) | $12.14M(+5.4%) |
| Mar 2010 | - | $2.95M(-14.9%) | $11.52M(+2.2%) |
| Dec 2009 | $11.27M(+13.9%) | $3.46M(+32.4%) | $11.27M(+6.1%) |
| Sep 2009 | - | $2.61M(+4.6%) | $10.62M(+2.0%) |
| Jun 2009 | - | $2.50M(-7.3%) | $10.41M(+31.6%) |
| Mar 2009 | - | $2.69M(-4.4%) | $7.91M(+51.6%) |
| Dec 2008 | $9.89M(+14.9%) | $2.82M(+17.2%) | $5.22M(+117.2%) |
| Sep 2008 | - | $2.40M(+103.5%) | $2.40M(-43.6%) |
| Dec 2007 | $8.61M(+17.9%) | - | - |
| Dec 2006 | $7.31M(+34.9%) | - | - |
| Dec 2005 | $5.42M(+45.6%) | - | - |
| Sep 2004 | - | $1.18M(+11.4%) | $4.26M(+6.1%) |
| Jun 2004 | - | $1.06M(+3.7%) | $4.02M(+4.2%) |
| Mar 2004 | - | $1.02M(+2.1%) | $3.86M(+3.7%) |
| Dec 2003 | $3.72M(+37.4%) | $1.00M(+6.9%) | $3.72M(+1.8%) |
| Sep 2003 | - | $936.00K(+4.3%) | $3.65M(+5.6%) |
| Jun 2003 | - | $897.00K(+1.4%) | $3.46M(+12.2%) |
| Mar 2003 | - | $885.00K(-5.2%) | $3.08M(+13.8%) |
| Dec 2002 | $2.71M(-53.6%) | $934.00K(+26.0%) | $2.71M(-9.8%) |
| Sep 2002 | - | $741.00K(+42.5%) | $3.00M(-21.1%) |
| Jun 2002 | - | $520.00K(+1.6%) | $3.80M(-23.9%) |
| Mar 2002 | - | $512.00K(-58.3%) | $5.00M(-14.3%) |
| Dec 2001 | $5.83M(-2.1%) | $1.23M(-20.5%) | $5.83M(+48.4%) |
| Sep 2001 | - | $1.54M(-9.9%) | $3.93M(-33.8%) |
| Jun 2001 | - | $1.71M(+27.5%) | $5.93M(+2.9%) |
| Mar 2001 | - | $1.34M(-299.4%) | $5.76M(-3.2%) |
| Dec 2000 | $5.96M(+575.2%) | -$674.00K(-119.0%) | $5.96M(-14.4%) |
| Sep 2000 | - | $3.55M(+129.2%) | $6.96M(+93.5%) |
| Jun 2000 | - | $1.55M(+0.7%) | $3.59M(+61.0%) |
| Mar 2000 | - | $1.54M(+371.2%) | $2.23M(+153.1%) |
| Dec 1999 | $882.00K(+24.6%) | $326.00K(+76.2%) | $882.00K(+20.7%) |
| Sep 1999 | - | $185.00K(0.0%) | $731.00K(+1.4%) |
| Jun 1999 | - | $185.00K(-0.5%) | $721.00K(+0.6%) |
| Mar 1999 | - | $186.00K(+6.3%) | $717.00K(+1.3%) |
| Dec 1998 | $708.00K | $175.00K(0.0%) | $708.00K(+32.8%) |
| Sep 1998 | - | $175.00K(-3.3%) | $533.00K(+48.9%) |
| Jun 1998 | - | $181.00K(+2.3%) | $358.00K(+102.3%) |
| Mar 1998 | - | $177.00K | $177.00K |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual D&A year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly D&A year-on-year change?
- What is Amneal Pharmaceuticals, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. TTM D&A year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual depreciation & amortization?
The current annual D&A of AMRX is $236.19M
What is the all time high annual D&A for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual depreciation & amortization is $240.18M
What is Amneal Pharmaceuticals, Inc. annual D&A year-on-year change?
Over the past year, AMRX annual depreciation & amortization has changed by +$6.79M (+2.96%)
What is Amneal Pharmaceuticals, Inc. quarterly depreciation & amortization?
The current quarterly D&A of AMRX is $60.11M
What is the all time high quarterly D&A for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly depreciation & amortization is $66.13M
What is Amneal Pharmaceuticals, Inc. quarterly D&A year-on-year change?
Over the past year, AMRX quarterly depreciation & amortization has changed by +$4.54M (+8.17%)
What is Amneal Pharmaceuticals, Inc. TTM depreciation & amortization?
The current TTM D&A of AMRX is $245.36M
What is the all time high TTM D&A for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high TTM depreciation & amortization is $245.36M
What is Amneal Pharmaceuticals, Inc. TTM D&A year-on-year change?
Over the past year, AMRX TTM depreciation & amortization has changed by +$20.12M (+8.93%)